PharmaSUG2018paper·US·Real World EvidenceCombining Electronic Diary Seizure Data with Visit-Based Seizure Data in the MONEAD Study RW02See metadata
PharmaSUG2018paper·US·Real World EvidenceTriangulating Multiple Sources of Contradictory Prescription Data – a Real-World Case Study RW04See metadata
PharmaSUG2018paper·US·Real World EvidenceReal World Patients: The intersection of Real World Evidence and Episode of Care Analytics RW05See metadata
PharmaSUG2018paper·US·Real World EvidenceImproved Transparency in Key Operational Decisions in Real World Evidence RW06See metadata
PharmaSUG2018paper·US·Regulatory (FDA/PMDA)Common Data Related Review Issues and Prevention: A Statistical Reviewer’s Thoughts REG01See metadata
PharmaSUG2018paper·US·Regulatory (FDA/PMDA)What Medical Reviewers Can Do With Standardized Data and Metadata Received in Module 5 REG02See metadata
PharmaSUG2018paper·US·Regulatory (FDA/PMDA)Electronic Data Submission and Utilization in Japan REG03See metadata
PharmaSUG2018paper·China·SP - Statistics & PharmacokineticsSurvival Analysis to Cox PH Models with Time-varying Coefficients SP-11 BeijingSee metadata
PharmaSUG2018paper·China·SP - Statistics & PharmacokineticsA SAS Macro for Continuous Glucose Monitoring (CGM) Data Analysis SP-28 BeijingSee metadata
PharmaSUG2018paper·China·SP - Statistics & PharmacokineticsStatistical Programming Analysis of Percentage of Responders in Alzheimer’s Disease SP-48 BeijingSee metadata
PharmaSUG2018paper·China·SP - Statistics & PharmacokineticsSense and Censorability: Learn censoring techniques with ADTTE for your survival SP-63 BeijingSee metadata
PharmaSUG2018paper·China·SP - Statistics & PharmacokineticsLet’s Get FREQy with our Statistics: Data Driven Approach to Determining Appropriate Test Statistic SP-67 BeijingSee metadata
PharmaSUG2018paper·China·SP - Statistics & PharmacokineticsSeveral methods to test the proportional hazard assumption before applying cox models SP-75 BeijingSee metadata
PharmaSUG2018paper·China·SP - Statistics & PharmacokineticsIntroduction to iRECIST SP-81 BeijingSee metadata
PharmaSUG2018paper·US·Strategic ImplementationLet’s get to the Source and streamline it to the End SI01See metadata
PharmaSUG2018paper·US·Strategic ImplementationRisk-based Validation in Clinical Trial Reporting: Focus on What Matters Most SI02See metadata
PharmaSUG2018paper·US·Strategic ImplementationAn eSubmission Tracking Tool for both Components and Timelines SI03See metadata
PharmaSUG2018paper·US·Strategic ImplementationUsing Simulation to Create Enrollment Plans SI04See metadata
PharmaSUG2018paper·US·Strategic ImplementationInfrastructure Designed to Maximize Workflow SI05See metadata
PharmaSUG2018paper·US·Strategic ImplementationMachine Learning – Why we should know and How it works SI06See metadata